These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8982294)

  • 1. Transfusion of platelet concentrates--clinical evaluation of two preparations.
    Strindberg J; Berlin G
    Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
    Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
    Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion of platelet concentrates from pooled buffy-coats: comparison of bedside vs. prestorage leukofiltration.
    Müller-Steinhardt M; Schlenke P; Wagner T; Klüter H
    Transfus Med; 2000 Mar; 10(1):59-65. PubMed ID: 10760204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
    Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
    Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies.
    Eriksson L; Shanwell A; Gulliksson H; Högman CF; Svensson LA; Kristensen J; Berg B
    Vox Sang; 1993; 64(3):133-8. PubMed ID: 8484245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a new platelet pooling system for platelet concentrates led to a higher corrected count increment after transfusion: a comparative observational study of platelet concentrates before and after implementation.
    Dijkstra-Tiekstra MJ; van de Watering LM; Rondeel JM; Slomp J; de Wildt-Eggen J
    Transfus Med; 2014 Apr; 24(2):99-104. PubMed ID: 24506143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Fernández-Muñoz H; Plaza EM; Rivera-Caravaca JM; Candela MJ; Romera M; De Arriba F; Lozano ML; Vicente V; Heras I; Castilla-Llorente C; Rivera J
    Hematology; 2018 Oct; 23(9):712-718. PubMed ID: 29582705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
    Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
    Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
    Singh RP; Marwaha N; Malhotra P; Dash S
    Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats.
    Riccardi D; Raspollini E; Rebulla P; Pappalettera M; Marangoni F; Greppi N; Sirchia G
    Transfusion; 1997 May; 37(5):528-30. PubMed ID: 9149780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method.
    Muylle L; Wouters E; Peetermans ME
    Transfusion; 1996 Oct; 36(10):886-90. PubMed ID: 8863775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient.
    Tynngård N; Boknäs N; Trinks M; Dreimane A; Berlin G
    Transfusion; 2019 Feb; 59(2):723-728. PubMed ID: 30548486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system.
    Högman CF; Eriksson L; Wallvik J; Payrat JM
    Vox Sang; 1997; 73(4):212-9. PubMed ID: 9407638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
    Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
    Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
    van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
    Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-process cell counts during preparation of platelet concentrates from buffy coats.
    Stampfli R; Schaller M; Schenker T; Frey-Wettstein M; Hauser SP; Nydegger UE
    Transfus Sci; 1997 Dec; 18(4):495-503. PubMed ID: 10178672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.